Kiora Pharmaceuticals, Inc.: Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board

Salt Lake City, Utah--(Newsfile Corp. - February 1, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today the appointment of Erin Parsons as a new independent

Related Keywords

Salt Lake City ,Utah ,United States ,Erin Parson ,Erin Parsons ,Francina Agosti ,Paul Chaney ,Brianm Strem ,Utah Newsfile Corp ,Parsons Medical Communications ,Eyegate Pharmaceuticals Inc ,Kiora Pharmaceuticals Inc ,Nasdaq ,Executive Chairman ,Stephen From ,Eyegate Pharmaceuticals ,Lead Independent Director ,Dihydroorotate Dehydrogenase ,Private Securities Litigation Reform Act ,Annual Report ,Kiora ,Pharmaceuticals ,Ppoints ,Erin ,Arsons ,Board ,Directors ,Stephen ,Rom ,Etire ,